Literature DB >> 30519931

Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection.

Wuchao Li1,2,3, Liwen Zhang2,4, Chong Tian1,3, Hui Song1,3, Mengjie Fang2, Chaoen Hu2, Yali Zang2, Ying Cao3,5, Shiyuan Dai3,6, Fang Wang3,7, Di Dong2,4, Rongpin Wang8,9, Jie Tian10,11,12.   

Abstract

OBJECTIVES: The present study aimed to investigate the clinical prognostic significance of radiomics signature (R-signature) in patients with gastric cancer who had undergone radical resection.
METHODS: A total of 181 patients with gastric cancer who had undergone radical resection were enrolled in this retrospective study. The association between the R-signature and overall survival (OS) was assessed in the primary cohort and verified in the validation cohort. Furthermore, the performance of a radiomics nomogram integrating the R-signature and significant clinicopathological risk factors was evaluated.
RESULTS: The R-signature, which consisted of six imaging features, stratified patients with gastric cancer who had undergone radical resection into two prognostic risk groups in both cohorts. The radiomics nomogram incorporating R-signature and significant clinicopathological risk factors (T stage, N stage, and differentiation) exhibited significant prognostic superiority over clinical nomogram and R-signature alone (Harrell concordance index, 0.82 vs 0.71 and 0.82 vs 0.74, respectively, p < 0.001 in both analyses). All calibration curves showed remarkable consistency between predicted and actual survival, and decision curve analysis verified the usefulness of the radiomics nomogram for clinical practice.
CONCLUSIONS: The R-signature could be used to stratify patients with gastric cancer following radical resection into high- and low-risk groups. Furthermore, the radiomics nomogram provided better predictive accuracy than other predictive models and might aid clinicians with therapeutic decision-making and patient counseling. KEY POINTS: • Radiomics can stratify the gastric cancer patients following radical resection into high- and low-risk groups. • Radiomics can improve the prognostic value of TNM staging system. • Radiomics may facilitate personalized treatment of gastric cancer patients.

Entities:  

Keywords:  Multidetector computed tomography; Stomach neoplasms; Survival

Mesh:

Year:  2018        PMID: 30519931     DOI: 10.1007/s00330-018-5861-9

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  27 in total

1.  Adjuvant therapy for gastric cancer after D2 gastrectomy.

Authors:  Toshirou Nishida
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

Review 2.  Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM.

Authors:  Joseph P Weir
Journal:  J Strength Cond Res       Date:  2005-02       Impact factor: 3.775

Review 3.  Immunosurveillance in human non-viral cancers.

Authors:  Wolf Herman Fridman; Bernard Mlecnik; Gabriela Bindea; Franck Pagès; Jérôme Galon
Journal:  Curr Opin Immunol       Date:  2011-01-14       Impact factor: 7.486

4.  Extent of arterial tumor enhancement measured with preoperative MDCT gastrography is a prognostic factor in advanced gastric cancer after curative resection.

Authors:  Masahiro Komori; Yoshiki Asayama; Nobuhiro Fujita; Kiyohisa Hiraka; Daisuke Tsurumaru; Yoshihiro Kakeji; Hiroshi Honda
Journal:  AJR Am J Roentgenol       Date:  2013-08       Impact factor: 3.959

Review 5.  Radiomics: the process and the challenges.

Authors:  Virendra Kumar; Yuhua Gu; Satrajit Basu; Anders Berglund; Steven A Eschrich; Matthew B Schabath; Kenneth Forster; Hugo J W L Aerts; Andre Dekker; David Fenstermacher; Dmitry B Goldgof; Lawrence O Hall; Philippe Lambin; Yoganand Balagurunathan; Robert A Gatenby; Robert J Gillies
Journal:  Magn Reson Imaging       Date:  2012-08-13       Impact factor: 2.546

6.  Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.

Authors:  Yung-Jue Bang; Young-Woo Kim; Han-Kwang Yang; Hyun Cheol Chung; Young-Kyu Park; Kyung Hee Lee; Keun-Wook Lee; Yong Ho Kim; Sang-Ik Noh; Jae Yong Cho; Young Jae Mok; Yeul Hong Kim; Jiafu Ji; Ta-Sen Yeh; Peter Button; Florin Sirzén; Sung Hoon Noh
Journal:  Lancet       Date:  2012-01-07       Impact factor: 79.321

Review 7.  Radiomics: extracting more information from medical images using advanced feature analysis.

Authors:  Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts
Journal:  Eur J Cancer       Date:  2012-01-16       Impact factor: 9.162

8.  The hazards of hazard ratios.

Authors:  Miguel A Hernán
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822

9.  Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing.

Authors:  Jianjun Zhang; Junya Fujimoto; Jianhua Zhang; David C Wedge; Xingzhi Song; Jiexin Zhang; Sahil Seth; Chi-Wan Chow; Yu Cao; Curtis Gumbs; Kathryn A Gold; Neda Kalhor; Latasha Little; Harshad Mahadeshwar; Cesar Moran; Alexei Protopopov; Huandong Sun; Jiabin Tang; Xifeng Wu; Yuanqing Ye; William N William; J Jack Lee; John V Heymach; Waun Ki Hong; Stephen Swisher; Ignacio I Wistuba; P Andrew Futreal
Journal:  Science       Date:  2014-10-10       Impact factor: 47.728

Review 10.  Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging.

Authors:  Aaron M Rutman; Michael D Kuo
Journal:  Eur J Radiol       Date:  2009-03-19       Impact factor: 3.528

View more
  11 in total

1.  CT radiomics nomogram for the preoperative prediction of lymph node metastasis in gastric cancer.

Authors:  Yue Wang; Wei Liu; Yang Yu; Jing-Juan Liu; Hua-Dan Xue; Ya-Fei Qi; Jing Lei; Jian-Chun Yu; Zheng-Yu Jin
Journal:  Eur Radiol       Date:  2019-08-29       Impact factor: 5.315

Review 2.  Radiomics in precision medicine for gastric cancer: opportunities and challenges.

Authors:  Qiuying Chen; Lu Zhang; Shuyi Liu; Jingjing You; Luyan Chen; Zhe Jin; Shuixing Zhang; Bin Zhang
Journal:  Eur Radiol       Date:  2022-03-22       Impact factor: 7.034

3.  Computed tomography-based score model/nomogram for predicting technical and midterm outcomes in transjugular intrahepatic portosystemic shunt treatment for symptomatic portal cavernoma.

Authors:  Xiang-Ke Niu; Sushant Kumar Das; Hong-Lin Wu; Yong Chen
Journal:  World J Clin Cases       Date:  2020-03-06       Impact factor: 1.337

4.  A CT-based radiomics signature for evaluating tumor infiltrating Treg cells and outcome prediction of gastric cancer.

Authors:  Xujie Gao; Tingting Ma; Shuai Bai; Ying Liu; Yuwei Zhang; Yupeng Wu; Hui Li; Zhaoxiang Ye
Journal:  Ann Transl Med       Date:  2020-04

Review 5.  Imaging biomarkers in upper gastrointestinal cancers.

Authors:  Michela Gabelloni; Lorenzo Faggioni; Emanuele Neri
Journal:  BJR Open       Date:  2019-06-24

6.  Computed Tomography-Based Radiomics Nomogram: Potential to Predict Local Recurrence of Gastric Cancer After Radical Resection.

Authors:  Liebin Huang; Bao Feng; Yueyue Li; Yu Liu; Yehang Chen; Qinxian Chen; Changlin Li; Wensi Huang; Huimin Xue; Xuehua Li; Tao Zhou; Ronggang Li; Wansheng Long; Shi-Ting Feng
Journal:  Front Oncol       Date:  2021-09-02       Impact factor: 6.244

7.  Diagnostic Performance of Artificial Intelligence-Centred Systems in the Diagnosis and Postoperative Surveillance of Upper Gastrointestinal Malignancies Using Computed Tomography Imaging: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.

Authors:  Swathikan Chidambaram; Viknesh Sounderajah; Nick Maynard; Sheraz R Markar
Journal:  Ann Surg Oncol       Date:  2021-11-11       Impact factor: 5.344

8.  A CT-based radiomics nomogram for prediction of human epidermal growth factor receptor 2 status in patients with gastric cancer.

Authors:  Yexing Li; Zixuan Cheng; Olivier Gevaert; Lan He; Yanqi Huang; Xin Chen; Xiaomei Huang; Xiaomei Wu; Wen Zhang; Mengyi Dong; Jia Huang; Yucun Huang; Ting Xia; Changhong Liang; Zaiyi Liu
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

9.  A radiomics nomogram for the prediction of overall survival in patients with hepatocellular carcinoma after hepatectomy.

Authors:  Qinqin Liu; Jing Li; Fei Liu; Weilin Yang; Jingjing Ding; Weixia Chen; Yonggang Wei; Bo Li; Lu Zheng
Journal:  Cancer Imaging       Date:  2020-11-16       Impact factor: 3.909

10.  3D IFPN: Improved Feature Pyramid Network for Automatic Segmentation of Gastric Tumor.

Authors:  Haimei Li; Bing Liu; Yongtao Zhang; Chao Fu; Xiaowei Han; Lei Du; Wenwen Gao; Yue Chen; Xiuxiu Liu; Yige Wang; Tianfu Wang; Guolin Ma; Baiying Lei
Journal:  Front Oncol       Date:  2021-05-20       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.